Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Operating Cash Flow

Cash generated by the company's core business operations during the period.

Sanara MedTech Inc.NASDAQ: SMTI

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow grows, but more slowly than its trailing trend

Q1 FY2026 operating cash flow of $2.47M (cash outflow) rose 23.3% year over year, behind the +1575.6% change in trailing-twelve-month operating cash flow.

Context

  • Operating cash flow amounted to 6.6% of revenue in FY2025, up 6.6 pp from a year earlier.
  • Operating cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +23.3% toward the trailing-twelve-month pace of +1575.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.47M-162.5% QoQ
Last fiscal yearDec 2025
$6.79M+28634.4% YoY
LTMMar 2026
$6.32M+1575.6% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+23.3%——
1 year+28634.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
6.79M USD
Year-over-year change
+28634.4%

Operating Cash Flow vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1575.6% is the highest of 10, against a peer median of +16.9%.
  • Operating cash flow amounts to 5.9% of revenue for SMTI, versus a peer median of 19.6%.
SMTI Competitors
Operating Cash Flow for SMTI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TRDAEntrada Therapeutics, Inc.LTM Mar 2026$131.7M USD+141.5%+11.1%2295.2%
VMDViemed Healthcare, Inc.LTM Mar 2026$57.13M USD+40.1%+23.2%19.9%
TBRGTruBridge, Inc.LTM Mar 2026$46.66M USD+16.9%+4.5%13.5%
HITIHigh Tide Inc.LTM Apr 2026CA$25.22M CAD+1.7%+74.5%3.8%
SGHTSight Sciences, Inc.LTM Mar 2026$25.12M USD+3.9%-26.9%31.6%
NEONeoGenomics, Inc.LTM Jun 2026$22.05M USD+56.9%—2.9%
STXSStereotaxis, Inc.LTM Mar 2026$15.35M USD+93.5%+17.6%49.2%
XGNExagen Inc.LTM Mar 2026$13.37M USD-10.3%-24.9%19.6%
SMTISanara MedTech Inc.LTM Mar 2026$6.32M USD+1575.6%—5.9%
LFMDLifeMD, Inc.LTM Mar 2026$5.66M USD-63.2%—2.6%
Peer median (excluding SMTI) —+16.9%+11.1%19.6%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(7.99M)(8.09M)(4.44M)(9.91M)(27.66M)
Depreciation & Amortization596.98K2.37M3.68M4.92M28.56M
Deferred Income Tax0(5.84M)000
Stock-Based Compensation2.67M2.7M3.44M4.44M718.71K
Change in Working Capital(1.18M)517.62K(3.28M)(911.72K)(3.84M)
Accounts Receivables(774.81K)(2.27M)(1.73M)(4.54M)4.03M
Inventory(1.15M)(517.27K)(1.55M)1.44M(431.33K)
Accounts Payables99.13K(423.75K)575.15K(471.21K)1.24M
Other Working Capital645.56K3.73M(577.32K)2.66M(8.68M)
Other Non-Cash Items1.1M2.79M(2.64M)1.44M9.02M
Operating Cash Flow(4.81M)(5.55M)(3.25M)(23.78K)6.79M
Capital Expenditures(750.45K)(747.02K)(265.25K)(229.3K)(4.63M)
Acquisitions (Net)0(2.52M)(9.94M)00
Purchases of Investments(4.53M)(250K)0(5.3M)9.48M
Sales of Investments0000(2.96M)
Other Investing Activities(578.59K)(598.45K)650(1.1M)(10.47M)
Investing Cash Flow(5.28M)(3.51M)(10.21M)(6.61M)(8.36M)
Debt Repayment009.69M19.59M0
Common Stock Issued28.94M0911.37K00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(642.53K)(627.35K)(958.59K)(2.15M)(8.48M)
Financing Cash Flow28.3M(627.35K)9.64M17.37M(8.48M)
Effect of Forex Changes00000
Net Change in Cash18.2M(9.69M)(3.81M)10.73M(10.03M)
Free Cash Flow(5.56M)(6.3M)(3.51M)(253.08K)2.16M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.